TARDBP and amyotrophic lateral sclerosis: However, SOD1-ALS accounts for only < 2% of human ALS, and now appears to be a possible pathomechanistic outlier in the complex ALS landscape, because SOD1-ALS tissue does not show the TDP-43 deposition seen in most ALS cases; for the same reason FUS-ALS may also be an outlier.